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CHAPTER I 
IN'I'RO DU C'riON 
This thesis constitutes a report on a series of 
studies undertaken on possible mechanisms of action of the 
bioflavonoid, · hesperidin methyl chalcone (HMC), in causing 
smooth muscle to relax. The term bioflavonoid refers to 
several compounds that can be extracted from the mesocarp of 
citrus fruits. 'l,hey have been the subject of investigation 
and controversy since 1936o Much of this is covered in a 
review by Vogin ( 1). As mentiioned in the review, Szent-
Gyorgyi observed first that crude citrus extracts were more 
efficient in relieving experimental scurvy than pure extracts 
containing only Vitamin c. The subject of scurvy has been 
covered in many reviews, and no purpose would be served in 
describing all these factors at t his time. However, since 
S zent~Gyorgyi's observation, there has been considerable 
study of the possibility that bioflavonoids are a factor in 
capillary integrity. Despite all the activity, the necessity 
of bioflavonoids as a dietary adjuvant has not been estab-
lished. At this date, almost thirty years after the initial 
studies, the literature is replete with contradictory state-
ments on almost every phase of bioflavonoid activity. 
In spite of the somewhat extensive literature dealing 
with these compounds, there ar e few references as to the 
2 
aeute effects following parenteral adminj.stration. Kikuchi, 
~ !1_ (2), reported that in anesthetized dogs, cats, and 
rabbits methylhesperidin caused a relatively slow fall .in 
blood pressure as a ·result of reduced · vascula;r tone. They 
reported that bio:f'1avonoids had little effect on the :rate 
and contractility of isolated perfused rabbit heart, while 
the coronary vasodilating effect was about one-fou~th that 
of theophylline. Aramaki, il ~ ()), found that methyl-
hesperidin, of unoertain chemical composition, at a dosage 
level of 50 to 100 milligrams per kilogram caused an GbVious 
depression of blood .pressure in rabbits and cats ,in proportion 
to the dose given. It also inhibited the rate and contracting 
power of rabbit atrium; this effect was reversible by washing. 
In an unpublished series of tests, Riedesel (4) observed that 
certain bioflavonoid compounds when given by intravenous 
injection to anesthetized dats had specific acute hy.po·t~n­
sive effects ranging from mild to severe and prolonged. 
In view of the limited studies on blood pressure 
reduction resulting from bioflavonoid administration, an 
ef;f;'ect not explained in the literature. it was decided to 
investigate the action of one compound, HMO,. in order to 
elucidate the meohanism or mechanisms involved~ I-UJIC was 
selected for study for several rea sons: (a} its avQilability 
as a reasonably pure compound, and (b) a ready solubility 
facilitating intravenous administration. This compound is 
prepared by a semisynthetic process from the naturally 
occuring biofls.vcmoial, hesperidin. Hesperidin is insoluble 
in water but can be converted to soluble hesperidin chalcone 
by alkali as illustrated in Figure 1. As seen in the illus~ 
tration, appropriate methylation preven·t;s acidic :rec0nversion 
of the chalcone to hesperidin, resulting in a permanently 
soluble form, hesperidin methyl chalcone. The molecular 
't'.reight of the commercial compound varies from 640 to 670, 
depending on the degree of methylation (5). 
(Hesperidin) 
l(o~ V)-ocM3 
Rh-o·f~("~,;-voH ---yY!H 
ow g 
(Hesperidin 
Chalcone) 
(Hesperidin Methyl 
Chalcone} 
Figure 1. Interconversion between hesperidin and hesperidin 
chalcone. 
~~Rh refers to the sugar rhamnose. 
*>:<This phenolic gr€>Up is one O.f those methylated in the 
formation of HMO, the methylation of which prevents recon ... 
version to hesperidin. 
CHAPTER II 
METHODS AND PROCEDURES 
I • MA TER~ALS 
All chemical reagents and drugs used throughout this 
investigation ;,are listed in the Appendix. 
II. EXPERIMENTAL 
The possibility that HNfC might have a direct act;ion 
on smooth muscle indicated that both in vivo and !a vitro 
studies . should be utilized. The in !J.Y .. o studies consisted 
of observations on .blaod p:ressure and nictitating membranes 
of cats. The in vitro studies were performed on sections of 
- ·--
rabbit ileum. 
In Vivo Studies 
The animals used in these studies were common domestic 
eats obtained from a licensed supplier of biological mate,.. 
rials. They were of both sexes and were maintained on Purina 
Cat Chow and water, ad libitum, The animals were anesthe-
tized with an intraperitoneal injection of sodium pento ... 
barbital, 50 milligrams per kilogram. BJ..ood pressu;r-e was 
directly recorded from the left femoral artery via a cannula 
to a blood pressure transducer. Impulses f:rom the transducer 
were recorded on a Physiograph Si;x:, a multichannel penwri·cing 
instrument manufactured by the E & M Instrument Company. 
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Norepinephrine and acetylcholj.ne v'lere injected prior 
to administration of HMC to standardize the response of the 
animaL Then they were injected after administration of HMC 
to determine if the bioflavonoid caused a departure from the 
previous responses~ The possibility that HMC might modify . 
vessel tone by a cholinergic mechanism was put to the te.srti 
by ascertaining what changes, if any, atropine sulfate pro-
duced in the response to the bioflavonoid. 
The r-elative accessibility of' the superior cervical 
sympathetic ganglion of the eat made possible a series of 
nictitating membrane studies to determine what ganglioplegic 
or adrenolytic effects. might result from administration of' HMC. 
In V.itro St.udies 
Preliminary work indicated that rabbit ileum was quite 
sensitive to the inhibitory effects C!>f HlVIC. Because of the 
ease of recording the inherently rhythmical contractions, 
this type of !Smooth muscle was selected f.'or the studies. 
The rabbits, o.f the type known as California Giant 
(Oryctolagus species unknown), were obtained from a licensed 
supplier of biological materials. They were maintained on 
Purina Rabbit Chow and water, ad libitum. Both sexes were 
used. Each animal was fasted from. eight to twelve hours 
prior to use. A typical ileum preparation was obtained in 
the following manner. A rabbit was stunned by a sharp blow 
·to the back of the head and was immediately exsanguinated. 
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The abdomen \'laS shaved with electric clippers and an incision 
was made along the linea alba. One and one~half to two 
centimeter sections of ileum were gently divested of mesen-
tery . These sections were sutured at both ends and removed 
from the rabbit anct were immediately placed in refrigera·ted 
Tyrode'$ solution (see Table I) at 3° c., for no longer than 
eight hours before use. 
The method employed in the intestinal strip studies 
\'las modified after Hoff and Geddes ( 6). A muscle strip was 
allowed to contract in Tyrodets solution contained in a 20 
milliliter capacity muscle warmer. ·rn.e solutions were main-· 
tained at a. temperature of 37.5° :t 0.5° c. Intermittent 
aeration was accomplished "t-li th a small respiratol"y pump. 
'rhe muscle warmer was arranged to permit rapid drainage of 
<1me fluid and .substitution of anotheri Contractions of the 
muscle st:rip s were reaorded by a Myograph B ·transducer on 
the Physiegraph. 
ChangEH~ !!1 e.lectr~l.:y~e cornpositi.Qn. The minimum 
effective quantity of HMC required to inhibit muscle c~:m"" 
tract.ion in 20 milliliters of Tyrode' s solution was deter-
mined empirically and found to be 10 milligrams. This con .. 
centration was then used as the standard coneentration for 
all succeeding studies, including studies where the muscle 
strips were caused to contract in solutions using modified 
TABLE I 
STOCK SALINE SOLUTIONS PREPARED FOR 
SMOOTH MUSCLE STUDIES ~< 
St andard Ca++ Free K+ Free 
7 
8X K+ 
·ryrode' s Tyrode'a Tyrode's Tyrode's 
Electrolyte 
NaCl 
KCl 
CaC,l2 
• 2H20 
MgCl;a 
• 2H20 
NaH2Po4 ·H~O 
NaHC03 
Dextrose 
Solution 
(A) 
7.$$ 
0,20 
O. i26 
0.10 
0,05 
1.oo 
1.00 
Solution 
( B ) 
7.98 
0.20 
...... 
0 .. 10 
0.05 
1. 00 
1.00 
Solution Solution 
(c) 
8.03 6w$2 
....... 1.60 
0.26 0·.26 
0.10 0.10 
0.05 0.05 
1.,00 1.00 
l.G>O 1.00 
The standard Tyrode's solution (A) was diluted with 
an appropriate quantity o.f modified solution (B or C) to 
prepare the modified ionic solut.ions shown in Table II . 
*All values are expressed as grams per liter of 
solution. 
TABLE II 
A SU.Ml1ARY OF THE ION CONCENr£RATIONS EMPLOYED 
I N EVALUATING THE EFFECT OF IiMC ON 
SMOOTH MUSCLE CONTRACT!ON):< 
Variations 
In K+ 
Ion Levels 
o.ooo 
o.oso 
0.100 
0.1$0 
lii600 
Variations 
In Oa++ 
Ion Levels 
o~ooo 
0.098 
0.153 
O.l$5 
0.228 
~~All values are @xpreesed in grams of potassium or 
caloimn ehloride per liter. 
>:<t)'.c:Rep;resents the amount of the ion found in standard 
Tyrodets solution. 
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concentration of electrolytes. The compGsition of' stock 
solutions prepared .for th·is work is shown in Table r. The 
diff'erene,es :tn tonicity resulting from changes in concentra .... 
tion of an electrolyte were adjusted by appropriate modifi-
cation of the sodium chloride conll!entration lAsing the sodium 
c.hloriq.e equivalent method (7) -
Solutions of diffe·ring ionic composition were S$lected 
originally as a matter of convenience, but sufficient varia~ 
tions were intredueed to provide a range from 0 to 100 per 
cent of the caleium OI" p{l)tassium. in Tyrode's solution, In 
addition, a series of salutions was prepared w-1 th an eight· ... 
fold. inerease in potassium ion as compared to standard •ryrode 's 
solution. These experimental solutions were prepared just 
pr'iol' to use from the stock solutions and are listed in 
Table II. :Cntermediate solutions (e.g~ ; one containing em e .... 
half er one-tourth the concentration of a eertain ion in 
standard Tyrode's solution) were prepared by a dilution of 
Ty:rodets solutift>n with the parti<Julat> stoek solution 'IJ>rithout 
th.at ion .• 
In each experiment, the muscle was allowed to assume 
a constant height and rate of contraction in prt:n.'la:rmed 
Tyrode's solution. When the rnuscle was stabilized, the:re 
was a rapid replacement of the Tyr0de's solution with the 
experimental solution; the time for complete exchange 
required less than ten seconds.. To this experimental solution 
was then added the HMC, a total of 10 milligrams dissolved 
in 0.5 milliliters of o.S5 per cent saline solution. Each 
experiment was repeated a minimum of eignt times. In 
several instances, a maximum of twelve successive experi ... 
ments were performed in order to assure reliability and 
r eproducibility. The observed tesults were recorded as 
changes in height of contraction, plotted against time. 
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Qardiotonie glygoside s:tu.dies. Cardiotonic glyeosides 
are known to enhance contractility of cardiac muscle by 
altering the way in which the cellular membrane handles 
potassium ($). On the assumption that cardiotonic glycosides 
might act in a similar manner on intestinal smooth muscle, 
a limited number o:(' experiments w~re conducted to determine 
if the glycosides fro~ digitalis would modify the response 
to HMC. 
Cof11pPl.rison .Q.f U:MQ wi.tb sodiwn versena:te. Calcium 
chelating agents such as disodium ethylenedia.minetetra·-
aoetate (sodium versenate) have been sho~m to inhibit con-
traction of glyc·erated skeletal muscle by E:bashi ( 9) and of 
vascular smooth muscle by Waug~ (10). The probable explana-
tion for the inhibition is that ealeium requisite for QGm-
traction is rendered unavailable to the contractile proteins 
(9). The possibility that HMC might inhibit muscle by cal.-
cium chelation was explored. Empirical studies determined 
11 
that the minimum effective .concen'tration of sodium versenate 
needed to inhihi t smooth musole.:was bett'reen 10 and 15 milli-
gr ams per .20 milliliters of. Ty:rodots. solUtion. This .amount 
of the chelating ~gent \'las added to muscles contracting in 
a solution with no potassium ion and the r .es1:1lts were compared 
to those produced by HMO under the same conditions. In addi -
tion, the calcium ehelating abilit:J.es · of H!JfC and sodium 
versenate were compared. Two different soluble electrolytes 
which form insoluble calmium precipitates were added to 
oalci.um chloride solutions containing either water, HMC, or 
sodium versenate. The amount 0f precipitant needed to cause 
permanent turbidity Q;f' a s$lution depended u~on the amount 
of unchelated calcium present. The solutions used are listed 
in Table II!. The results were recorded as milliliters of 
titrant needed to oa..use permanent turbidity and are presented 
in the ehapter on Resttlts. 
TABLE Ill 
SOl UTIONS .USED TO COMPARE THE CALCIUM: BI NDING ABILITIES 
OF APPROXIMATELY EQUlMOLAR SOLUTIONS OF 
Experimental 
Solut.ion 
· HMC AND ·SO'DIUM VERSENATE* 
12 
Tri~l i.# (15 
milliliters per 
soluti~n, each 
c'ontaining o •. 0~.3% 
calcium chloride 
plus the substance 
indicated),. 
Trial ·z.#l (30 
millili'ters per 
solution, eaeh 
containing 1.7% 
sodium potassium 
tartrate plus the 
substance ihdica.ted). 
Water 
Controls 
So).utions Gon ... 
tainlng Sodium 
Versenate 
Solutions Con ... 
taining HMC 
Sodium versenate (.o. :l.Ut-%). Only 
two determil;'lations. 
Sodiwn V'ersenate 1. 
. ( o. 24%). . 
HMC ( 0, .3 4%) • 
*Three determinations were made G.m each solution 
except where noted~ 
#ln Trial 1, 0.1 per ·cent sodi:um oxalate was added 
to each solution .from a burette until. 4ev~lopment of a 
permanent turbidity consisting of ealcium oxalate , 
4#i . 
1r, ln Trial 2, 2 .. 0 per eent calc!wn chlori~~ was added 
to eaeh solution. from a burette until development of a 
permanent turbidity consisting of calcium tartrate. 
CHAPTER III 
RESULTS 
.1!?- Vivo Studies 
The raw data for the in. vivo st udies are compiled 
in the Appendix. The bloed pressure measurements are 
presented as per cent increases or decreases, with the 
pressure at the time of injection taken to be 100 per cent. 
This proviCl.es a useful means of comparing bJ.ood pressure 
effects of d:Lfferent dosages and agents when the initial 
pressure varies 'lr.ridely from anima,l to animal. Comparisons 
between challenge doses and doses given after HMC for 
several agents with vascular effects are presented in 
Table IV, Parts A and B of Figure 2 graphically present 
these comparisons for norepinephrine and acetyl¢holine~ 
Injection ot atropine sulfate, 0,.5 milligrams per 
kilogram, did not greatly change the response to HMO when 
given befGre or aftel" the bioflavonoid. The atropine did 
abolish the blood pressure effects of intravenously admin-
istered acetylcholine. Parts C and D of Figure 2 demonstrate 
the differing effects of atropine on the vascular response 
to HfJIC and to acetylcholine. 
Stimulation of the preganglionic fibers of the left 
superior cervica l ganglion caused contractions of the left 
nictitating membrane and dilations of the pupil that were 
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11ABLE IV 
COMPARI SON BETWEEN CHALLENGE DOSES 
AND DOSES GIVEN AFTER HMC* 
Agent and Dose 
Acetylcholine~ 
1.0 mcg./Kg. 
Norepinephrine, 
0.2 mcg./Kg. 
0.2 mcgp/ Kg . 
0.,2 mcg. / Kg. 
1.0 mcg./Kg. 
Epinephrine; 
0.2 mcg./Kg. 
Pituitary · 
Extract; 
2.5 units 
SlQod Pr~ssure Responses 
(as I?er c,e:nt cha.n~es) 
Before fiMC: After HMC 
66. fall 
44 rise 
16 ris.e 
14 rise 
37.5 rise 
26 rise 
41 rise 
63 £all 
46 rise 
l9 rise 
25 rise 
J$ rise 
5$ :rise 
27 rise 
Y.<Tabulated from three animals .. 
Remark a 
No change. 
The varj. a.tions 
between the before 
and after responses 
are considered 
to be of no 
significance. 
Greater rise in 
pressure after HMC . 
The vaaeular bed 
seemed less 
reactive after HMC. 
15 
Figure 2. Representative blood pressure changes caused by 
norepinephrine, acetylchol:Lne, and HMC. 
A, Average incre&se caused by nerepinephrine given before 
and after HMC (three animals), · 
B~ Changes caused by aoetylcholine, 1.0 mcg./Kg., when 
given as challenge dose and after HMC (one animal) o 
c . Changes caused by HMC, 50 mg ./Kg •• given before and 
afte~ atropine sulfatet. 0.5 mg.JKg. · 
D. Changes in ·pressure caused by acetylcholine, 2,0 
. meg,. / Kg ., given before and after the same dose of 
atropine given in C. 
16 
undiminished by large doses of HMO (up to 150 milligrams per 
kilogram), Tbe response to preganglionic stimttlation was 
greatly reduaed by the administrat:i.<rm of the adrenergic 
blocking agent phentolamine hydrochloride. The rsespGnse was 
completely abolished in another a.nimal by the ganglionic 
blocking agent hexemethoniurn chloride . 
In Vitro Studies 
performed as described in the 0hap:t er :. on Methods .. The records 
were ana.lyt.ed in the i'oll.Qwin~ manner. Actual contraction 
excursions of the recorcti·ng pen were bonverted t o . percentages 
of ii.n.itis.l eontraetion which G:lllowed comparison of records 
with differing initial heights of ·contraction. The percent-. 
age values were plot.ted ag;ainst time in seeonds :following 
exposure to HMC. 'X'he data from which the graphs were drawn 
appear in the Appendix.~ Because there was some variation 
among the contra~tion heights of the members of a. series ., a 
line representing the mean. ·per cent height of contraction 
was plotted against time for each experimental oGndition. 
The mean was calculated at time intervals representing .3, 6, 
12, 20 ., and .:34 sec0nd$ after addition of · HMO to the perfusing 
solution. Figure .3 illustrates the mean response to HMC of 
muscles contracting in Ty:rode's solution. The mean height of 
c0ntraction for muscles contracting in Tyrode's solution 
' -
' g 
'' 
±1: ; 
!- ' 
L. 
-
' 
,,, 
f-R~ ~~ . II~ 
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Figl.lre ). C())mparison between mean heights of contraet.ion 
for muscles contracting in Tyrode's solution (12 trials) 
and for muscles in Tyr•ode' e solution to which HMO was 
added (l~ t:rials). {The difference between ·the line at 
20 seconds is significant at the 0.99 leve1..) 
(when no HMC was. added) is also shown in F'igure 3 for 
comparisen. Statistical analys;t.;s (Student ... t) was performed 
on the two cu:ttves at the distance representing 20 seconds 
and the difference between the curves was found to be signi-
ficant at the o. 99 level. 'rhe standard deviat.ions in both 
cases are essentially the same and are probably representa• 
tive of the variability inherent in this partieular biolQgical 
system. 
Figures 4 through 12 show the responses to HMO 
obtained in the several ion deficient solutions, In each 
figure, the curve representing the response to HMC of 
muscl es in Tyrode's solution is added for eomparison and the 
level of statis.ltical signi.fieance between the two curves is 
noted, The curves representing responses significantly 
differing from the response obtained i.n Tyr.ode's solution 
are compiled in Figure 13 . 
The e:ffeet of addition of 10 milligrams of HMC to 
museles in Tyrode•s solution (Figure .3) was. a profound inhi-
bi tl,.on of ecmtraction. The m0di£i.ed Ty:rode' s solutions that 
provided s.ignifieant ·antagonism to the inhibitory action or 
HMC were those containing one.-hal f' or 'less Qf' the potassium 
or calcium in standard Tyr0de's sol ut ion. 
A t;,ypical record.i obtained 'ir:then the Tyr dde t s sci'lut i on 
was exchanged for a solutiEm conta.tn:in-g an ei ght fo l d i ncrease· 
19 
·, .. 
Figure 4• Mean response to HMC of muscle$ contracting in 
modified Tyrode's solution containing 0 .. 150 grams of 
potassium chloride per liter (10 trials). (The response 
does nG>t differ significantly from that obtained in 
Tyrode's solution,) 
' 
_, 
j; ~ - ~;<;: -
1-- _j_,_ -
-
.. r: 
r 
I -~ - : _ ) 
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I-~'igur-e 5. Mean :resfonee to HMC of_ muscles contracting in 
modified Tyrode s soluti0n c¢ntaining 0.100 grams of 
potassium chloride per liter (10 trials). (The differ-
ence between the curves :is significant at the 0~95 
leveL) 
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Figure 6. Mean res}l>onse to HlVIO of muscles contracting in 
modified Tyrode's solution containing 0 ,050 grams of 
potassium chloride per liter (10 trials ) . (1ihe di ffer ... 
enee between the curves is significant at the 0.95 
level. ) 
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Figure 7. Mean resfonse _ to HMC of museles c~ntrcaoting in 
modified Tyrade s solution d0ntaining no potassium 
(12 trials). (The difference between t he curves is 
significant at the 0, 99 level. ) 
Fig'tire .8. Mean response to HMC of musoles contr acting in 
modified Tyrode ' s SQluti~n cont$.ini ng 0,-24g grams of 
ealeium chl0ride per l iter (10 tlrials ) . (The differ ... 
enoe between the curves is not significant .) 
Figure 9 ~ Mean response to HMC of muscles ecmtracting in 
modified Tyrode 1 s solution containing 0~1S5 grams of . 
calcium chloride per liter (10 trials ) . (The differ-. 
ence between the curves is not significant.) 
Figure 10, Mean response to fllJlC of museles contraeting in 
modified Tyrode's solution containing 0 . 15.3 g:rams of 
calcium chloride per liter ( 9 trials ) . (The response 
does not differ significantly from that in Tyrode's 
solution .) 
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Figure 11. Mean response to HMO of muscles contracting in 
modified Tyrode's solution containing 0.098 grams of 
calciiun chloride per liter (8 trials). (The difference 
between the · curves is significant. at the 0, 95 level.) 
Figm:-e 12. Mean response to HMO O·f muscles eont.racting in 
modified Tyl"ocle's solution containing no oalc:ium 
(9 trials}. (The difference between the curves is 
significant at the 0. 99 level, ) 
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Figure 1.3 . Response curves wi ·th signifi cant departures 
from the respcmse obtai ned in standard Tyr 0de' s 
so l ution, 
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in potass-ium, is shown in Figure 14.. A state of sustained 
contraction re$ulted from the expesure tG the high potassium 
concentration, a state very similar to the contracture 
caused by excess potassium on the heart (11). This contrac-
ture was reversed by addition of HMC after which the muscle 
returned to prev;t,ous rhythmic contraction. 
1' t 1' 1' · 
A. B. G. o: 
100 Sec. I . 
Figure 14~ Effect of an eightfold increase in potassium 
foll0wed by addition of HMC. 
A, Normal contractions. 
B. Exchange to solution containing eightfold increase 
in potassium. 
C, Addition of 10 milligrams of HMO. 
D. Resumption of rhythmic contractions. 
Cardiotonie gl:Y:cos,ides. As little as 0. 025 units of 
the glycosides of digitalis caused increased contractility 
of the muscle strips, In a. typical experiment this am0unt 
was added to the bath. The muscle responded with an increased 
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height of contraction. Then 5 milligrams of HMC were added 
and the height. decreased to its original value. Another 
addition of digitalis, o~o; units, cau$ed another increase 
in height 't~hioh was reversed by 10 milligrams 0! Hl"!C.. Th:i..s 
and similar experiments were perforne~ which showed digitalis 
and HMO to be mutually antagonistic in their effects on con-
traction. In all cases, the gl.ycosides were able to r ·everse 
the response to HMC and HMC was able to rev·erse the response 
to digit.alis. The significance o£ this antagonism will be 
discussed in the Disaussiwm part of the thesis. 
Com:gari~on with sgd.iwn verse.nate. Less than l.O 
milligram amounts of sodium versenate lowered ·the .frequency 
o:£ contraction.; otherwise, there appeared to be no resp<~>nse. 
Amounts g;reater than lO milligr~ns quickly inhibited muscle 
strips. Jl.1usales contracting in pota.ssium;wfree Tyrod.e' s 
solutions wel:'e immediately inhibited when 15 milligrams of 
the ehelating agent were added~ Tnis inhibition was in 
direet contrast to the antagonism to HMC provided by 
potassium...,free solutions (Figure 7, page 22), 
The attempt to measure the chelating ability of HMC 
by titration (ra\'T data tabulated in the Appendix) gave the 
results in Table V. In both cases, the $olutions containing 
HMC needed slightly more titrant than did the water controls. 
But that differen~e is insignificant when o.ompared to the 
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much greater amounts taken by solutions containing sodium 
versenate. 
TABLE V 
A VERAGF: MILLII.ITERS OF TI'I"RANT NEEDED 
'1'0 DEVELOP PERMANENT TURBIDITY 
'frial 1, cal.cium. 
Experimental oxalate indicator; 
solut.ions sodium oxalate 
added 
Water controls 0.44 
Solutions con ... 
taining HMC 0~99 
Solutions con ... 
taining sodium 
versenate 12.40 
Trial 2, calcium 
tartrate indieator; 
calcium chloride 
added 
4.77 
The differences between the action of HtviC and sodium 
versenate eliQited in potassium ... free soluti~ns make it 
improbable that HI ... IC and sodium ve:rsenate inhibit smooth 
muscle by the same mechanism. The paueity or calcium binding 
shown by HMC in the ti t»raticm studies adds support to the 
same co.nclusion. 
CHAPTER tV 
DISCUSSION 
CJ:'he effects produ¢ed by not:'epineph;i:;ine; injected 
before a,nd after HMC . ( F'igure :a, page 1;) .•. were not greatly , 
changed -by the bioflavonoid. HrlfC was unable to dimin:l,sh 
the nictitating membt"ane eontrae~i'i)n ·s and pupil dilations 
resulting from stimulation of c.ervical _sympa:thetic fibers 
while phentolamine was able to do so. These results could 
be taken to indicate that the bioflavonoid dees not cause 
reduc-ed blood pressure by an adrenolyttic mechanism. The 
undiminished nictitating membrane and pupil response also 
indicate that the bioflavonoid apparently is not a ganglio-
plegie agent. Hexamethonium, in contrast, eompletely 
abolished the effects of preganglionic stimulation. 
Sin.oe a ;fall in bl0od pressure sGme.times follows 
administ:ration of a cholinergic drug , the possibility that 
HMC might have a similar effect could not be overlooked. 
Howe"'te:r , as shown in the section on results, atropine sulfate, 
a typical anticholinergic. did not prevent the hypotensive 
effect of HMC, but did protect against a blood pressure drop 
when acetylcholine was injected (Figure 2, parts C and D). 
The elimination of the mechanisms tested in the !n 
v.i vo studies suggests that HMG might have a direct action on 
the muscle cells. The results from the various i .n ..:..V.:::.i..;:ot.::..r;;;.o 
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studie$ support the hypothesis that HMC inhibits contraction 
by rendering the cell membranes impermeable tG potassium 
efflux or to other ionic shifts occuring with contraction. 
This conclusion is reached from observing that the solutions 
or agents which interfere with the effect of HMC are ones 
which seem to facilitate potassium efflux or produce a 
decrease in the amount of intracellular potassium. 
As commented t:m by Thomas ( 12), potassium iGn has 
differing intracellular and extraeellular actions on smooth 
muscle. The presence of intracellular potassium inhibits 
contraoti~n of cardiac muscle and other types of muscle by 
reversible competition with calcium for reactive sites on 
the contractile proteins or on a relaxing factor. Thus, if 
the concentrati.on of intracellula;r potassium decreases or 
calcium increases, contraction will occur~ A low concentra ... 
tion of potassium in the external environment stimulates 
contraction by two possible mechanisms. The first possd-
bility. similar to one proposed by Armitage (1.3) for cardiae 
muscle~ is one concerned with ionic gradients. The intra ... 
cellular potassium can migrate outward more easily against 
the reduced potassium concentration. An alternate possi .. 
bility is a mechanism similar to that in heart muscle in 
which decreased ext,racellular potassium causes increased 
calcium influx (12). Either mechanism might conceivably 
reverse the inhibitory effect of HMC . 
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A reduced concentration of calcium in the external 
environment decreased the inhibitory effect of HMC. It is 
believed (12 ) that calcium plays two different roles in 
contractile processes. According to this theory , the first 
role of calcium is to provide a link between cell membrane 
excitation and contraction~ Bound calcium is released from 
storage sites on the cell membrane by excitation and enters 
the cell to cause contraction. It does this either by 
directly activating contr~etile mechanisms or by inac·tivating 
a relaxing system that normally prevents contraction (11:,). 
This explains the increased contractility that might result 
from the augmented calcium influx produced by reduced extra-
cellular potassium . The second role played by calcium is in 
regulating membrane polarity and permeability~ High external 
calcium concentration reduces spike frequency , potassium 
efflux , and spontaneous muscle tone by stabilizing the cell 
membrane {15). Gonversely , reduction of the external cal-
cium produces membrane instability resulting in increased 
spike frequency , increased potassium efflux, a partial 
depolarization , and increased tonus (16 ) . This stimulating 
effeotJ though short in duration , is the probable explana-
tion of low calcium antagonism of the bioflavonoid. 
As discussed in the previous paragraphs ; both low 
calcium and low potassium in the external environment cause 
an increased efflux of potassium and both were shown to 
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antagonize the effect of HMO (Figure 1), page 28). It is 
reasonable to speculate that HMC might cause inhibition of 
muscle by hindering potassium efflux or other ionic shifts; 
perhaps by decreasing the permeability of the cell membrane . 
Cardiotonic glycosides which were found in our work 
to reverse the effects of HMO are reported by Kahn,!! al (g), 
to cause the amount o.r intracellular potassium to decrease. 
This is accG>mplished by a decrease in the rate of potassium 
influx following contra.ction. 'l'he glycosides do not appear 
to change the rate of potassium efflux. This is in agreement 
with our observa:tiQns that a change in the handling of 
potassium by the · cell membrane :reverstl!d the acrtion of HIViO 
which suggests that the bioflavonoid might be producing a 
modification of potassium exchange by the cell membrane. 
High external potassium concentration caU$es 
contracture in many types of' muscle including arterial seg-
ments ( 17), intestinal muscle ( 1$} ~ and eardiac muscle ( 11}. 
A suf.ficient increa$e in extrac·ellular potassium depolarizes 
the muscle membrane~ This causes the release of bound cal~ 
cium which migrates trans~ellularly resulting in contracture 
(12). As shown in Figure 14, page 29, HMO reversed the con-
tracture of the eightfold increase o£ pota$sium ion, thus 
allowing the muscle to resume rhythmical contractions, 
although of a somewhat diminished amplitude. This partieular 
observa.tion is not contradictory to the previous observations 
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where HMC decreased contraction, but actually substantiates 
the former conclusi~n of interferenoe with iG>nic transport, 
In the first instance , HI.JIC decreases amplitude of contraction 
by preventing potassium efflux or calcium shifts ., thus inter ... 
fering with the intracellular contractile mechanisms. ln 
the second instance, which is purely an extreme experimental 
si tuaticm, excess potassi'Um eauses apparent depolarization 
which allows the release of bound caleiurn resulting in con .. 
traction. HMO by the same membrane stabilization which 
pre.vents efflux of potassium in Tyrod.e' s solution allows 
relaxation of the muscle by preventing the excess potassium 
from depolarizing. 
That these conclusions are possible is supported by 
Steinberger, et il, (19), who provide evidence that bioflavo-
noids can alter ionic transport. '11hey found that peritoneal 
absorption of isotonic sodium chloride was substantially 
decreased in rats treated with phosphorylated hesperidin. 
They also reported that the bioflavonoid caused decreased 
permeability of mouse connective tissue membranes 1u vitro. 
Additional evidence is provided by Cal l and Patterson (20) 
who reported that a lemon biC::>flavo.noid complex protected 
rats against normally lethal do$es of ephedrine and epine-
phrine. They concluded that the protection was probably 
caused by decreased absorption of the toxic agents. It is 
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very tempting to assume a relationship between the decreased 
transport of ions and drugs and the decreased permeability 
to potassium hypothesized previously. 
CHAPTER V 
CONCLUSION 
Thj.s thesis reports studies on the mechani$Ill$ 
underlying the blood pressure reduction and smooth muscle 
inhibition caused by the bioflavonoid hesperidin methyl 
chalcone. Experiments on intact circulatory systems and 
nictitating membranes of cats ruled out adrenolytio, 
ganglioplegic, and cholinergic mechanisms for the lowering 
of blood pressure. 
Studies on smooth muscle in vitro (rabbit ileum) 
showed that the inhibition caused by the bioflavonoid was 
reversible by low potassium or low calcium concentration in 
the surrounding .fluid. The bioflavonoid reversed the con• 
tracture caused by an eightfold inerease of po·cassiurn in 
the external environment and allowed resumption of rhythmic 
contraction. Cardiotonic glycosides and HMC \-Jere found to 
be mutually antagonistic in their effects on contraction. 
It is concluded tha.t HMC may have its smooth muscle 
depressant effect by virtue 0f causing decreased membrane 
permeability to ions er by interfering with membrane 
transport mechanisms. 
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APPENDIX 
APPENDIX 
I, DRUGS AND REAGENTS USED 
B;i.o.flavonoiQ.. 
Hesperidin Methyl Chalcone D-3442. Commercial 
produot. 
Reagent Grad~ f~ateria.ls, used in physiological s0lutions. 
Sodium Chloride. 
,Potas§iurn. Ohlo;r:ide. 
Calcium Chloride, Dihydrate. 
Magnesium Chlor'ide. Hexahydrate. 
Monobasic Sodium Phos;ehate; Monohydrate. 
Sodium J2icarb.onate, 
Dy;x~rese. 
Reagent Grade Materials , used in titration studies. 
D.isogimn Ethxlene,d~aminetet;r:ga.cetate. ( Sodiwn 
Versenate) • 
Sodium O;xal.ate. 
Sodium Potassil.!m 'l'artrate, Tetrahydrate. (Rochelle 
Salt~-N . F, Grade). 
U. S. P. G:J?ade dpr.ugs. 
Aoetxlchol.ine Ohlori.de, 
Ngre'Qil)~pbtin.,e Hydro ghlori~e. 
Post~rior Pi;tyi_tary ~astraot. 
PhentolJJinine Hzdroohloride. 
Hexam,e~honi.;um ChlQr.ide. 
Epinei(hri.ne, Hxdro,chlox·.i<le. 
Pentobarbital Sod;t_um. 
Pig!talis GlYcos:i.g~s. (Digiglusin-.... Lilly) , 
A~ropine Sulfat<-7• 
II. IN VIVO EXPERIMENTS 
Blood Pre§sUr® Studie$ 
The data for these experiments are given in outline 
form. The tesults of injeot:lon of various compounds are 
presented in the order injected, Blood pressure changes 
are reported as percentages wi15h the pressure at the time 
of injeetion taken to be 100 per cent. All of the original 
records are in the files of the Department of Physiology-
Pharmacology. 
I. 9/ 24/ 63. The subject of this experiment was a 4 kilogram 
male cat. Blood pressure wa s recorded on an ink 
writing kymograph by a "U" tube mercury manometer. 
a. Challenge Doses. 
1. Norepinephrine 1 0.1 microgram (meg. ) per kilogx-am (Kg. ) , caused a 50 per eent rise. 
2. Norepinephrine, 0,2 mcg. / Kg., caused a 44 per 
cent rise. 
3. Acetylcholine (AOh ) , 1.0 mcg . / Kg., caused a 
68 per cent fall. 
4. ACh, 2~0 mcg./Kg., caused a 94 per cent fall. 
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b. Experimental Doses. 
2. 
6. 
8. 
9. 
10. 
11~ 
HMC t 25 milligrams (mg. ) / Kg. , caused a 58 per 
cent fall. 
HMC, 25 mg./Kg., caused a 57 per cent fall. 
HMG, 50 mg./Kg., caused an $1 per cent fall. 
Atropine sulfate, 0.5 mg./Kg., caused a very 
transient fall in pressure; 27 per cent. 
HMC, 50 mg./Kg. The pressure fell from 93 to 
40 millimeters (mm.) of mercury (Hg) at ninety 
seconds · after injection. 'lpJhile it was still 
falling, the follol'Ting dose of atropine was 
given. 
Atropine sulfate, 0.5 mg~ /Kg. The pressure 
continued to £all and fell to 28 mm. Hg within 
ninety seconds after this injection and then 
held steady, a 70 per cent total fall after 
HMC. 
Atropine sulfate; 1-.0 mg./Kg., given nine 
minutes from the preVi(!)US dose; the pressure 
fell from 20 to $ mm~ Hg •. 
Norepinephrine , 0.2 mcg./Kg., caused a 46 per 
cent rise. 
A series of massive doses of norepinephrine 
was given ($5 meg. total dose). 
ACh, 2.0 mcg./Kg., caused no change in pressure, 
showing that the atropine was still effective. 
HMC, 100 mg./Kg. The pressure fell from 35 to 
4 mm. Hg. · Although the atropine was still 
effective, it did not reverse the hypotensive 
aetion of the bioflavonoid. 
II. 10/.31/6). The subject of this experiment was a ;3.5 
kilogram male cat. Arterial pressure was recorded 
by transducer from the left femoral artery, and an 
electrocardiogram was recorded simultaneously to 
measure heart rate. 
a. Challenge Doses. 
J 
1. AOh, 1. 0 meg. / Kg . , causes a 66 per cent fall 
and the heart rate decrea.sed. 
2, Norepinephrine, 0.1 mcg. / Kg., caused a 22 per 
cent fall in pressure. This unexpected 
result might be caused by ACh left in the 
vein from the previous injection. 
3. Norepinephrine, 0.1 mcg. / Kg ., caused a 5 per 
eent rise. 
4. Norepinephrine, 0.2 mcg./Kg., caused a 16 per 
cent rise and the heart rate was unchanged .. 
5. Norepinephrine, 1.0 meg./Kg., caused a 37.5 
per cent rise. 
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6. Epinephrine, 0.1 mcg./Kg., caused an ll per 
cent rise .in pressure and an increased heart 
rate. 
7. Epinephrine, 0.2 mcg./Kg., caused a 26 per cent 
rise. 
S. Pentobarbital sodium, 12.5 mg., caused a 30 
per cent fall in pressnlre... This is the 
expected vascular response to barbiturate 
injection. 
b. Experimental Doses . 
1. HMO, 25 mg ./Kg. , caused a 19 per cent fall in 
pressure with an unchanged heart rate. 
2. HMC , 50 mg ./Kg., eaused a 43 per cent fall 
with no change in heart rate. 
3. Norepinephrine, 0.2 mcg./Kg.; caused a 19 per 
cent rise. 
4. Norepinephrine~ 1.0 mcg ./Kg, , caused a J$ per 
cent rise. The heart rate was unchanged. 
5. Epinephrine, 0.2 mcg./Kg., caused a 5$ per cent 
:rise. 
6. ACh, 1.0 mcg./Kg~, caused a 63 per cent fall. 
7, Pituitary extract, 10 unitsj caused a 78 per 
cent rise with no change in heart :rate, 
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8. HMO, 50 mg. /Kg. , caused a, 62 per cent fall. 
9. Hexamethonium chloride, 12 mg., caused a 32 per 
cent fall. There was a small decrease in 
heart rate .. 
III. 11/ 19/ 6). A 2. 7 Kg. female cat was the subject of this 
experiment. Nictitating membrane studies were per ... 
formed simultaneously with the blood pressure work. 
a ~ Challenge Doses. 
1. ACh, 1.0 mcg. / Kg., caused a 71 per cent fall. 
2. Norepinephrine, 0,2 mcg. / Kg., caused a 14 per 
cent rise . 
). Pentobarbital sodi~, 10 mg~, eaused a tran~ 
sient fall in pressure. 
4. Pituitary extract, 2. 5 units, caused a. 41 per 
cent l ... ise, 
b~ Experimental Doses. 
L 
2. 
6. 
7. 
Atropine sulfate, 0 . 5 mg. / Kg., caused a very 
slight and transient rise in pressure. 
J\.Ch , 1. 0 meg. / Kg . , caused an 11 per cent fall 
in comparison with a 71 per cent fall before 
atropine~ 
HMG; 50 mg . / Kg. , caused a 51 per cent fall . 
(Approximate l y J ... l / 2 minutes after 3. ) HMC ~ 
50 mg. / Kg., caused a )0 per oent fall , 
(Approximately 5 minutes after 4.) HMC, 50 
mg./Kg. , caused an 18 par eent fall~ 
Norepinephrine, 0.2 mcg./Kg ., caused a 25 per 
cent rise -. 
Pituitary extract , 2.5 units, caused a 27 per 
cent :rise. 
Hexamethonium chloride, 12 mg. total dose, 
caused a gradual decline in blood pressure. 
Nictitating Membrane Stud;i.es 
The significant findings from this work are presented 
in the chapter on Results. All of the Physiogra.ph records 
are on file in the Department of Physiology-Pharmacology. 
III. I N VITRO STUDIES 
The Physiograph records (on file in the Department of 
Physiology ... Pharmacology) were handled in the following 
manner. The heights of r ecorded contraction were measured 
and converted into percentages with the height at the time 
of addition of HMC taken to be 100 per cent. 'l'he valu9s 
for each member of a series were plotted as line graphs 
versus time in seconds after addition of HMO. The mean per 
cent height of recorded contractions were calculated at 3, 
6, 12, 20, and 34 seconds after addition of the bioflavonoid . 
The significance of the deviation of each response from that 
in Tyrode's solution was calculated at the 20 second time 
value. The Student ... t test was used. These curves and com-
parisons are presented in the chapter on Results. The raw 
data from which the line graphs were drawn are compiled in 
this section. 
I H ' 
Table l 
Data .from 12 forty-second time periods of muscle contracting in Tyrode's 
solution. The origin of each run was chosen arbitrarily .. 
D* H 
12/15/63 4.03 
A.. 3.88 
4.10 
4.10 
4.20 
B. 3. 78 
4-.10 
3.85 
3.92 
3.69 
c. 3. 50 
3.33 
3 ... .20 
,3.18 
3.38 
D. 3.30 
2 .. 98 
3.35 
3.25 
).25 
s 
100 0 
96 10 
102 20 
102 30 
104. 40 
100 0 
109 10 
102 20 
104 30 
98 40 
100 0 
95 10 
91 20 
91 30 
96 40 
100 0 
90 10 
102 20 
99 30 
99 40 
D H % S 
2/4./64 3.06 100 0 
A. 3.20 105 10 
3~4.2 ll2 20 
2 06 · a .... ; 30 . ./ . ;; 
3.13 102 40 
B. 2 .. 20 100 0 
1 •. 95 89 10 
1.89 86 20 
1.99 91 30 
1 .• 65 75 40 
2/13/64 2.25 100 0 
A. 2.05 91 10 
2.60 116 20 
2.50 111 30 
2.18 97 40 
B. 3.88 100 0 
4.00 103 10 
3.12 81 20 
3.55 92 30 
4,.22 109 40 
D H % S 
2/20/64 2.20 100 0 
A. 2 ... 40 109 10 
2 08 9 '"' 20 • ' :> 
2 .• 38 108 30 
1.90 87 40 
B. · 3.82 100 0 
3.65 96 10 
3 .. 32 $7 20 
3.20 84 30 
3.50 92 40 
3/16/64 2~50 100 0 
A. · 2.56 102 10 
2 •. 60 104 20 
2.60 104 30 
2 .• 70 108 4.0 
B. · 2.30 100 0 
2.30 100 10 
2.30 100 20 
2.32 101 )0 
2.20 96 40 
The mean per cent heights of contraction were -99.8 , · 99.3, · 98 .. 6, .98.2, and 
98.0 at 3, 6, 12, 20,. and 34 seconds, respe.ctive1y. 
*D = date and experiment letter on the original Physiograph ·record; H = 
measured height of recorded contraction in c·entimeters; % = calculated per cent 
he:ight of re-corded contraction ; S = time in seconds after the arbitrary starting 
point,. 
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1'able 2 
Response to HMC of' muscles contracting 
in 'l'yrode' s solution 
D)!C H % e .;) D H % s 
2/4/64 2.05 100 0 2/4/64 .3 .. 65 100 0 
1. 1.30 64 5 17. 2.25 62 6 
0 .. 92 45 11 1~94 53 17 
0.68 33 32 1.75 48 30 
0.58 39 39 1. 55 42 '37 
5· 2.83 100 0 18. 3.30 100 0 2.25 80 6 2.00 61 3 
1.56 55 14 1.62 49 12 
1.22 43 22 1.38 42 20 
0.72 25 27 1.32 40 27 
0.52 18 31 1.18 36 35 
0 • .36 13 41 
19. 2.68 100 0 
15. 2.50 100 0 1.90 71 4 
2.)5 94 9 1.38 52 11 
2.20 8$ 12 1.30 49 26 
1.7$ 71 21 1.15 43 39 
1. 55 62 30 
1.35 54 33 20. 2.20 100 0 
1.28 51 39 1.04 47 9 
0.78 35 14 
16. 3.30 100 0 0.60 27 24 
2.05 62 4 0.56 25 29 
1.88 57 17 0.40 H! 35 
1.50 46 24 
1.20 36 28 
1.04 32 34 
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Table 2 (continued) 
D H % s D H % s 
~ 
2/4/64 
21. 
22. 
3.60 
2.40 
1.60 
1,46 
0.$$ 
2.25 
1.85 
1~10 
0.72 
0,69 
100 0 
67 7 
45 10 
41 20 
24 33 
100 0 
82 10 
49 18 
32 22 
.31 .34 
2/4/64 2.70 100 
2.3. 1,75 65 
1.22 45 
0,8$ 33 
0.70 26 
0.60 22 
24. 2.24 100 
1.89 84 
1.30 58 
1.07 48 
0.92 41 
0.78 35 
0.60 27 
0.50 22 
· The mean per cent heights of contraction were 81,0, 
69.7, 45.0, and 31.7 at 3, 6, 12, 20, and 34 seconds, 
respectively. 
0 
3 
12 
20 
25 
.35 
0 
4 
9 
18 
2.3 
24 
33 
42 
):(D = date and experiment number on the original 
Physiog:raph reoord; H = measured height of recorded contrac-
tion in centimeters; % = per cent height of recorded con-
traction; S = time in seconds after addition of HMC. 
Table 3 
Response to HMC of muscles contracting in modified 
Tyrode's solution (0.150 grams 
7. 
$. 
2/l3/64II 
1. 
pota.·s sium chloride per liter) 
H % 
2.43 100 
1.90 78 
1~2) 51 
0.97 40 
0,77 32 
0.48 20 
0.42 17 
0.37 15 
2. 26 100 
1.85 82 
1,19 53 
0.81 36 
0.63 28 
0.38 17 
2~72 100 
2.52 93 
1~00 37 
0~ 75 28 
0.58 21 
ol' ;o 18 
2.58 100 
1.87 73 
1.35 52 
l~ 20. 47 
0.99 38 
0,73 28 
0.60 23 
3.67 100 
4.80 76 
2~10 57 
1.50 41 
1.02 28 
0 .. 70 19 
0.49 13 
s 
0 
4 
10 
15 
20 
26 
31 
39 
0 
a 
10 
19 
41 
37 
0 
6 
16 
21 
31 
41 
0 
4 
10 
15 
21 
27 
34 
0 
7 
21 
24 
28 
33 
37 
D 
2/lJ/64 . z. II 
). 
6. 
H 
3.10 
2.02 
1~18 
1.08 
0.64 
0.52 
0.40 
3.50 
2.72 
2.25 
1.83 
1.52 
1.20 
0.92 
3.16 
l. 75 
1~20 
1.00 
0.72 
2.85 
2.$8 
1. 56 
0.90 
0~70 
0.58 
2.55 
1.60 
1.20 
0.99 
0.61 
0.50 
% 
100 
65 
39 
35 
21 
17 
13 
100 
78 
64 
52 
43 
34 
24 
100 
55 
38 
32 
23 
100 
90 
55 
32 
25 
20 
100 
63 
1/1 
31 
24 
20 
52 
s 
0 
9 16 
20 
24 
28 
35 
0 
9 
18 
23 
29 
33 
40 
0 
9 
21 
30 
39 
0 
3 
10 
22 
29 
44 
0 
4 
14 
25 
33 
40 
The mean per cent heights of contraction were $7.3, 
76~2, 55.3, 40.1, and 21.8 at 3, 6, 12, 20, and 34 seconds, 
respectively. · 
*For key, see Table 2. 
Table 4 
,r esponse to HMC of muscles contracting in modified 
Tyrode's solution {0.100 grams potassium 
chloride per liter) 
D* 
2/13/64rr 7. . 
8. 
2. 
J. 
H 
2 .. 32 
1.83 
1.70 
1.50 
2.50 
1.90 
1.60 
L.43 
1.10 
0.97 
0.83 
.3. 43 
);20 
2~62 
2,50 
1.50 
o,eo 
0.72 
0.47 
4.05 ).88 
.3.31 
2.)5 
1.80 
4.42 
3.38 
2.95 
4.70 
2.0.3 
1.40 
% 
100 
79 
74 6; 
100 
76 
64 
57 
44 
.39 
3.3 
100 ' 
93 
76 
73 
44 
23 
21 
14 
100 
96 
82 
58 
45 
100 
77 
67 
61 
46 
.32 
0 
16 
.33 
39 
0 
4 
17 
22 
27 
31 
35 
0 
ll-
6 
10 
21 
24 
29 
43 
0 
9 
17 
26 
34 
0 
7 17 
22 
28 
36 
D. 
5. 
6. 
8. 
H 
4.1$ 
3.0; 
2.50 
2.00 
~-40 
1.06 
,3,20 
2.62 
2.)0 
2.00 
1.70 
).30 
2.90 
2.42 
2.18 1.ea 
1.60 
2.80 
2,00 
1.74 
1.38 
1.08 
2o58 
2.10 
1.82 
1.62 
% 
100 
73 
60 
48 
-33 
25 
100 
82 
72 
63 
53 
100 gg 
73 
66 
57 
l.,.9 
100 
71 
62 
49 
.38 
100 
81 
70 
64 
53 
s 
0 
3 13 
23 
28 
38 
0 
4 
16 
29 
)9 
0 
; 
14 
24 
30 
35 
0 
13 
21 
29 
35 
0 
10 
25 
35 
The ·mean per cent heights of contraction were 90.0, 
83.2, 75.2, 64.7, and 45.0 at 3, 6, 12, 20, and 34 seconds, 
respectively. 
*For key, see Table 2. 
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'l'able 5 
Response to HMO of muscles contracting in modified 
'fyrode's solution (0.050 grams potassium 
chloride per liter} 
D..,, .,, 
2/13/64r 
1. 
2. 
4. 
H % S 
3~22 100 0 
2,60 81 1). 
2.45 76 24 
2. 00 62 3~-
3.37 100 0 
2.80 $) 12 
2.53 75 23 
1.90 56 2$ 
1.30 39 44 
2 .. 90 100 0 
2.20 76 11 
1.94 67 29 
1.70 59 46 
2.87 100 0 
2.55 89 4 
2.06 72 11 
1.67 ·ss zo 
1.20 42 ~2 
1.05 37 35 
2 • .32 100 0 
1.$5 80 20 
1.74 75 33 
1.56 67 50 
D 
2/20/641 
.3. 
6. 
H % S 
2 • .50 100 0 
l. 56 62 5 
1.35 54 11 
1.10 44 17 
0.97 39 24 
0.88 .35 30 
o. 75 30 43 
2.10 100 0 
1.70 81 5 
1.19 57 11 
o.ee 42 23 
o.so 3$ 38 
2 • .39 100 0 
1.76 74 ll-
1 .. 19 50 11 
0.95 40 16 
0.7.3 31 29 
0.69 29 42 
2.64 100 0 
1.42 54 12 
1.34 51 20 
Ll5 44 26 
0.90 34 39 
2.42 100 0 
2.00 $) 5 
1.4§ 60 12 
1 .• 20 50 20 
1.00 /~1 26 
0.$9 37 40 
The ·mean per cent heights of contraction were 90.5, 
81 ,2, 66.9~ 58 .9, and 46.9 at ), 6, 12, 20, and 34 seconds, 
respectively. · 
*For key, see Table 2. 
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1?able 6 
Response to HMC of muscles contr~.cting in 
modified Tyrode's solution 
with no potassium 
o~:< H % s · D H % :a 
2/4/64 2~73 100 0 9. 3.57 100 0 
2. .2.00 73 7 :;.oo . 84 10 
1.40 51 17 2.90 . Sl 25 
l. 2.3 45 41 2.60 ' ·73 46 
3. 4~'37 100 0 ;tO. ),20 100 0 
2.00 46 10 2.JO 72 10 
1.52 35 29 2 .• 10 . 66 23 
1.29 30 40 1.88 59 32 
4. 3.42 100 0 11. 3.10 100 0 
2.,38 70 12 2 •. 66 86 5 
2.00 58 27 2.43 ' 78 20 
1.90 56 41 2.26 73 35 
6. 3.oo 100 0 12, 2.90 100 0 
2.61 87 $ 2.46 $5 5 
2.30 77 22 2.2~- 77 15 
2.12 71 J7 2.19 76 25 
2.06 71 48 
7. 2.70 100 0 
2.45 91 4 13. 2.8; 100 0 
2~35 $7 22 2.42 85 5 
2.28 84 37 2.30 81 15 
2.03 · 71 .30 
8. 3. 7.3 100 0 2,08· 73 48 
3,00 81 4 2_6, 71 13 14. 2.55 100 0 
2 .• )6 63 30 2.10 82 6 
2.13 57 41 2.00 78 16 
1.90 75 25 
1.81 71 )3 
1.72 67 46 
'rhe ·mean pe;r cent heights of contraction were 90.6, · 
83~1, 75.0, 70.5, and 65.0 at 3, 6, 12, 20, and 34 seconds, 
respeeti vely. 
*For key, see Table 2. 
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Table 7 
Respanse to HMO of muscles contracting in modified 
Tyrode's solution (0.228 grams calcium 
chloride per liter) 
D>:( H % s D H % s 
2/20/641 2.41 100 0 2/2~:64II a. 4f3 100 0 8. 1.27 53 6 1.66 67 6 
1.13 47 11 1.16 47 10 
1.00 41 17 1.00 40 17 
0.88 36 23 0.90 36 23 
0.78 32 37 o.6s 27 30 
0.50 20 34 
9. 2.20 100 0 
1.31 60 6 ). 3-48 100 0 
1.13 51 14 2.76 79 4 
1,00 45 20 1.66 48 10 
1.00 45 26 1.32 .38 16 
0.87 40 .35 0.92 26 23 
o.so 23 35 
10 .• 2~27 100 0 
1.98 E!7 5 4. 2.85 100 0 
1.10 49 11 l. 73 61 7 
0.92 40 17 1.30 46 13 
0.92 40 30 0.91 32 19 
o.en .36 43 0,80 28 26 
0.65 23 37 
11. 1.95 100 0 
1.10 56 6 5. 3.13 100 0 
0.97 50 13 2.15 69 6 
0.90 46 24 1.17 37 12 
0.$2 42 36 0.90 29 19 
2/20/64II 
0.74 24 30 
2.08 100 0 0.71 23 37 
1. 1.70 82 5 
1.08 52 8 6. 2.80 100 0 
0.,64 .31 13 1.67 60 8 
0.52 25 19 0.90 32 13 
0~34 16 28 0.87 .31 19 
0.32 15 35 o.63 23 29 
0.60 21 36 
The mean per cent heights of contraction were 82.5, 
65.3, 44.3, 35.4, and 28.1 at 3, 6, 12, 20 and 34 seconds~ , 
respectively. 
:>!<For key, see Table 2. 
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Table g 
Response to HMC of muscles contracting in modified 
Tyrode's s0lUtion (0.1$5 grams calcium 
chloride per liter) 
D)!C H % s D H % s 
2/20/64rr 2.so 100 0 12. ; p.6o 100 0 
7. 1.00 36 6 ~~45 6$ 6 
0.70 25 15 1.80 50 12 
o~ss 21 22 1~38 38 19 
0.70 25 .30 1.35 37 30 
0.60 21 40 0.90 25 33 
0.80 22 .39 8. 2.86 100 0 
2.00 70 5 13. 2.88 100 0 
1~24 43 9 1.63 57 4 
1.20 42 17 1.40· 49 11 
0.90 31 21 1.29 45 18 
0.70 24 28 0.90 .31 24 
o.;o 17 37 0.75 26 31 
0.50 17 .38 
9. 2.90 100 0 
0.94 32 6 14. 3.07 100 0 
0.80 2$ 13 2.$0 91 10 
0.66 2.3 26 2 .. 25 7.3 l4 
0.70 24 32 1.$2 59 19 
0.66 23 39 1.49 49 23 
1.,30 42 29 
10. 4.40 100 0 0.97 .32 39 
3.63 $2 6 
.3.50 80 13 15. 2,90 100 0 
2.90 66 18 2.45 $4 6 
1.62 37 22 1.57 54 10 
L23 28 28 1.48 51 16 
1.10 25 41 1.39 48 22 
1.10 38 34 
11. 2.84 100 0 
1.19 42 5 16. ~L42 100 0 
0~97 34 12 1.60 66 5 
o.eo 28 24 1.20 50 11 
0.60 21 29 0.80 3.3 15 
0.50 18 .33 0.54 22 27 
0.45 16 40 0.40 17 .31 
0.35 15 50 
The ·mean per cent heights of contraction were 78.0, 
61.3, 4£3.9, 37.3, and 24.8 at 3, 6, 12, 20; a.nd 34 seconds, 
respectively. 
>:~For key , see Table 2. 
Table 9 
Response to HMC of muscles contracting in modified 
1'yrode t s sQlution ( 0.153 grams calcium 
chloride per liter) 
2/20/64rr 
17. 
18, 
20. 
2/20/64rrr 
1. 
H % 
2~60 100 
1~56 60 
1.24 48 
0.93 36 
0.70 27 
o. 57 22 
2i65 100 
2~45 92 
l. 73 6; 
1.$5 5$ 
1-00 38 
o.6o 2.:3 
2.58 100 
1~66 64 
1.~o 47 
o. 72 28 
o.65 25 
1.98 100 
1,08 55 
0.90 45 
0.65 3.3 
0,47 24 
2.65 100 
2.10 79 
1~84 69 
l!l41 ?3 
1.00 38 
0 ,80 )0 
s 
0 
11 
17 
24 
29 
44 
0 
7 
13 
23 
32 
40 
0 
7 
18 
28 
37 
0 
10 
18 
26 
)7 
0 
10 
17 
24 
29 
36 
D 
2. 
,3. 
H % 
.3~15 100 
2"95 94 
1,55 49 
1.30 41 
0~82 26 
o.;o 16 
0.40 13 
).00 100 
1.95 65 
1.06 35 
0.40 13 
0.-38 1.3 
0.22 7 
3.84 100 
2.70 70 
2.00 52 
1.55 40 
1.44 .38 
LOO 26 
o ·~ 98 25 
3.60 100 
2.10 58 
1~12 .31 
0.64 18 
0,65 18 
s 
0 
6 
14 
21 
27 
33 
41 
0 
3 
14 
18 
28 
33 
0 
6 
12 
17 
22 
.30 
.36 
0 
7 
18 
28 
35 
The mean per cent heights of contraction were 86.1, 
75.8, 56.2, 41,2 and 24.2 at 3, 6, 12, 20, and 34 seconds, 
respectively. · 
*For key, see Table 2. 
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Table 10 
Response to HMC of muscles contracting in modified 
Tyrode'.s solution (0.098 grams calcium 
chloride per liter) 
D>:~ H % s D. H % s 
2/20/64rrr 2.3.3 100 0 10. 4.25 100 0 
6.. l~$7 80 5 3.30 78 5 1,26 54 13 2~45 58 11 
0,80 34 21 2.16 51 22 
0.35 15 26 2.00 47 28 
0.35 15 .33 1.85 44 42 
0.30 13 39 
11. 4.40 100·. 0 
7. 4 .. 55 100 0 4.10 93 ~ 
3.72 80 6 2.95 67 12 ).50 75 14 2. 60 59 28 
2~64 57 21 2 • . 50 57 37 
2.37 51 26 
2.10 45 32 12. 4~10 100 0 
1.62 35 44 3.80 93 g 3.45 $4 14 
8. 4.55 100 0 2·.47 60 24 
3.40 75 10 2.40 59 .37 
2~80 62 19 
2.70 59 23 13. 4.00 100 0 
2.70 55 30 ;3.75 94 5 
2.50 48 36 2.95 74 11 
2 • .50 63 23 
9. 4.18 100 0 2.40 60 .30 
3.7$ 90 9 2.1; 54 43 
2.90 69 15 
2~78 66 2~. 
2.70 65 30 
2.50 60 38 
The ·mean per cent heig;hts of contraction were 91.9, 
84.6, 71.1, 59.lt and 48.0 at 3, 6, 12., 20, and 34 seconds, 
respectively. 
>:(For key, see Table 2. 
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Table 11 
Response to HMC of muscles contracting in 
modified Tyrode•s solution 
11<rith no calcium 
n):~ H % s n H % s 
2/20/64111 3.08 100 0 2/20/64rv 3.05 100 0 14. 1.95 63 6 ). 2.70 88 7 
2.52 82 14 2.37 7s 20 . 
2,46 80 19 2 • .30 7$ 28 . 
1.70 55 34 2.28 74 41 
15. 2.65 100 0 4. 4.30 100 0 
2.48 94 5 3.49 81 5 
2.65 100 12 2.65 61 17 
2-.55 96 28 2.40 56 30 
2.00 76 39 2.28 53 45 
16. 3.10 100 0 5. 3.85 100 0 
2.86 96 4 3.40 8$ 10 
2.24 72 16 2.36 61 22 
2.43 7S 27 1.86 48 40 
2l00 64 41 
6. ,3.68 100 0 
2/20/64rv 1.55 100 0 3.40 92 4 
1. 1.10 71 7 2.65 72 19 
1.07 69 16 1.90 52 31 
0.97 63 26 1.85 50 43 
0.84 54 38 
2. 3.50 100 0 
3.10 S9 8 
2.90 83 17 
2.70 77 36 
'l'he mean per cent heights of' contraction were 92.4, 
85,0, 81.2, 74.6, and 63.4 at 3, 6, 12, 20, and 34 seconds, 
respectively. 
~'For key, see 'rable 2. 
Table 12 
Milliliters of titrant need~d to develop 
permanent turbidity--comparison of 
HMC with sodium versenate 
-
Solution 
Number 
1 
2 
3 
Average 
Solution 
Number 
1 
2 
3 
Average 
'r:rial 1, sodium oxalate added 
Water Solution Solution with 
Controls with HMC Sodium Versenate 
0.60 1.16 12.30 
0.40 0.81 12.50 
0.33 1.00 ...... 
O.L,4 0.99 12.40 
Trial 2, calcium chloride added 
Water S:olution Solution with 
Controls with Hr\'lC Sodiuxn Versenate 
4.63 4.84 6.35 
4.47 4.71 6 .. 60 
5.20 5.04 5.86 
4.77 4.86 6.27 
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